BRPI0807798A2 - " aperfeiçoamento do crescimento celular ". - Google Patents
" aperfeiçoamento do crescimento celular ".Info
- Publication number
- BRPI0807798A2 BRPI0807798A2 BRPI0807798-3A2A BRPI0807798A BRPI0807798A2 BR PI0807798 A2 BRPI0807798 A2 BR PI0807798A2 BR PI0807798 A BRPI0807798 A BR PI0807798A BR PI0807798 A2 BRPI0807798 A2 BR PI0807798A2
- Authority
- BR
- Brazil
- Prior art keywords
- improvement
- cell growth
- growth
- cell
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
- C12N9/0026—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5)
- C12N9/0028—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5) with NAD or NADP as acceptor (1.5.1)
- C12N9/003—Dihydrofolate reductase [DHFR] (1.5.1.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07101070A EP1953222A1 (en) | 2007-01-24 | 2007-01-24 | Improvement of cell growth |
| PCT/EP2008/050699 WO2008090148A2 (en) | 2007-01-24 | 2008-01-22 | Improvement of cell growth |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0807798A2 true BRPI0807798A2 (pt) | 2014-06-03 |
Family
ID=38006916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0807798-3A2A BRPI0807798A2 (pt) | 2007-01-24 | 2008-01-22 | " aperfeiçoamento do crescimento celular ". |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8535940B2 (pt) |
| EP (2) | EP1953222A1 (pt) |
| JP (1) | JP2010516264A (pt) |
| KR (1) | KR20090112725A (pt) |
| CN (1) | CN101589140B (pt) |
| AU (1) | AU2008208862B2 (pt) |
| BR (1) | BRPI0807798A2 (pt) |
| CA (1) | CA2675344A1 (pt) |
| EA (1) | EA018099B1 (pt) |
| HK (1) | HK1137482A1 (pt) |
| IL (1) | IL199639A (pt) |
| MX (1) | MX2009007790A (pt) |
| NZ (1) | NZ579204A (pt) |
| WO (1) | WO2008090148A2 (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1953222A1 (en) | 2007-01-24 | 2008-08-06 | Boehringer Ingelheim Pharma GmbH & Co. KG | Improvement of cell growth |
| WO2010010108A1 (en) * | 2008-07-23 | 2010-01-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Improved production host cell lines |
| KR101706399B1 (ko) | 2009-02-27 | 2017-02-13 | 노파르티스 아게 | 이종성 단백질을 발현하는 진핵 세포의 선택 방법 |
| SG11201504564TA (en) | 2012-12-10 | 2015-08-28 | Seikagaku Kogyo Co Ltd | Novel recombinant factor c and method for producing the same, and method for measuring endotoxin |
| SG11201703741TA (en) * | 2014-11-12 | 2017-06-29 | Prometic Pharma Smt Ltd | Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration |
| CN107119018B (zh) * | 2017-03-30 | 2020-08-18 | 陕西师范大学 | 一种抗凋亡细胞系及其建立方法和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2238070T3 (es) | 1989-04-21 | 2005-08-16 | Amgen Inc. | Receptor del tnf, proteina ligante del tnf y adn codante para estos. |
| US6221675B1 (en) | 1989-04-21 | 2001-04-24 | Amgen, Inc. | TNF receptors, TNF binding proteins and DNAs coding for them |
| US5776746A (en) | 1996-05-01 | 1998-07-07 | Genitope Corporation | Gene amplification methods |
| US20030219871A1 (en) | 2002-03-28 | 2003-11-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Host cells having improved cell survival properties and methods to generate such cells |
| EP1348758A1 (en) * | 2002-03-28 | 2003-10-01 | Boehringer Ingelheim Pharma GmbH & Co.KG | Host cells having improved cell survival properties and methods to generate such cells |
| EP1953222A1 (en) | 2007-01-24 | 2008-08-06 | Boehringer Ingelheim Pharma GmbH & Co. KG | Improvement of cell growth |
-
2007
- 2007-01-24 EP EP07101070A patent/EP1953222A1/en not_active Withdrawn
-
2008
- 2008-01-22 MX MX2009007790A patent/MX2009007790A/es active IP Right Grant
- 2008-01-22 WO PCT/EP2008/050699 patent/WO2008090148A2/en active Application Filing
- 2008-01-22 AU AU2008208862A patent/AU2008208862B2/en not_active Ceased
- 2008-01-22 EP EP08735407A patent/EP2126061A2/en not_active Withdrawn
- 2008-01-22 NZ NZ579204A patent/NZ579204A/en not_active IP Right Cessation
- 2008-01-22 KR KR1020097017534A patent/KR20090112725A/ko active IP Right Grant
- 2008-01-22 JP JP2009546739A patent/JP2010516264A/ja active Pending
- 2008-01-22 US US12/524,219 patent/US8535940B2/en active Active
- 2008-01-22 CA CA002675344A patent/CA2675344A1/en not_active Abandoned
- 2008-01-22 CN CN2008800030457A patent/CN101589140B/zh not_active Expired - Fee Related
- 2008-01-22 BR BRPI0807798-3A2A patent/BRPI0807798A2/pt not_active IP Right Cessation
- 2008-01-22 EA EA200900984A patent/EA018099B1/ru not_active IP Right Cessation
-
2009
- 2009-07-01 IL IL199639A patent/IL199639A/en not_active IP Right Cessation
-
2010
- 2010-03-31 HK HK10103312.3A patent/HK1137482A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HK1137482A1 (en) | 2010-07-30 |
| CA2675344A1 (en) | 2008-07-31 |
| EA200900984A1 (ru) | 2010-02-26 |
| WO2008090148A3 (en) | 2008-09-18 |
| EP1953222A1 (en) | 2008-08-06 |
| AU2008208862A1 (en) | 2008-07-31 |
| IL199639A (en) | 2013-08-29 |
| EP2126061A2 (en) | 2009-12-02 |
| NZ579204A (en) | 2012-04-27 |
| EA018099B1 (ru) | 2013-05-30 |
| IL199639A0 (en) | 2010-04-15 |
| JP2010516264A (ja) | 2010-05-20 |
| KR20090112725A (ko) | 2009-10-28 |
| MX2009007790A (es) | 2009-07-31 |
| US20100086967A1 (en) | 2010-04-08 |
| US8535940B2 (en) | 2013-09-17 |
| CN101589140B (zh) | 2013-04-17 |
| WO2008090148A2 (en) | 2008-07-31 |
| CN101589140A (zh) | 2009-11-25 |
| AU2008208862B2 (en) | 2014-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0716762A2 (pt) | melhorias da cultura celular | |
| BRPI0818536A2 (pt) | Linhagem celular cho-k1 | |
| CL2007002310S1 (es) | Telefono celular. | |
| BRPI0919919A2 (pt) | transplante celular | |
| BRPI0814894A2 (pt) | Diferenciação de células-tronco embrionárias de ser humano. | |
| BRPI0913806A2 (pt) | "composição" | |
| BRPI0816970A2 (pt) | 1,3-dissubstituídas-4-fenil-1h-piridin-2-onas | |
| BRPI0820145A2 (pt) | "vestimenta" | |
| DK2205562T3 (da) | 1,1,1-trifluor-2-hydroxy-3-phenylpropanderivater | |
| DE602006014483D1 (de) | Gewebekulturmikroskop | |
| MA30949B1 (fr) | MYRTILLE NOMME "DrisBlueTwo" | |
| BRPI0714209A2 (pt) | Induzidor de morte celular | |
| BRPI0914533A2 (pt) | "métodos" | |
| IT1392533B1 (it) | Composizione di aerosol con supporto acquoso. | |
| ITGE20050091A1 (it) | Incubatrice | |
| BRPI0807798A2 (pt) | " aperfeiçoamento do crescimento celular ". | |
| DK2119776T3 (da) | Dagblomst- flavonoid-3',5'-hydroxylase-gen | |
| DE112006002477A5 (de) | Elektrolyt | |
| BRPI0819979A2 (pt) | tratamento de biomassa celular eucariótica | |
| MA30860B1 (fr) | Myrtillier denomme "c97-390" | |
| DK1956892T3 (da) | Fiskestang | |
| FR2920157B1 (fr) | Nouvelles souches de levure de panification | |
| BRPI0906053A2 (pt) | "enzima artificial" | |
| BRPI0810272A2 (pt) | "construção habitável" | |
| IT1398988B1 (it) | "macchina taglia-tronchi" |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |